ABOUT ABS

Advanced Biomimetic Sensors is compromised of a team with vast experience who is always on the cutting edge of energy technology and innovation.

Ellen T. Chen

ELLEN T. CHEN, Ph.D. is the founder and the CEO of Advanced Biomimetic Sensors, Inc. from 2006 to the present. Dr. Chen has 27 years of experience in developing innovative nanobiomimetic systems for reagent-free sensing, and electrolyte-free and air-independent energy storage. Dr. Chen invented more than a dozen issued patents and a dozen pending patents applications. Dr. Chen led ABS received two National Innovation awards, and a dozen national showcase awards. She published more than 70 peer-reviewed articles, three book chapters, and one college textbook. Dr. Chen gave more than 25 invited public presentations at national and international conferences. Prior Dr. Chen founded ABS, she worked as a Principal Investigator (PI), and a Project Manager in conducting innovative research for more than 12 years at U.S. Food and Drug Administration (US FDA). Dr. Chen was a former Scientific Representative in Vitro Diagnostic medical devices from 1997 to 2001 for FDA. Her multiple-center clinical research projects in the evaluation of self-monitoring blood glucose (SMBG) medical devices in the market, had won FDA’s highest research award. Dr. Chen received 12 awards in medical device research and consultations to regulatory science at USFDA. Dr. Chen’s current research interests involve developments of biomimetic sensor and energy storage systems, nanotechnology, room-temperature quantum sensing, and energy storage. Dr. Chen was a referee for several prestigious peer-reviewed journals in the fields of analytical chemistry and microsensors. Dr. Chen received her Ph.D. degree in analytical chemistry from Purdue University in 1994 and her master’s degree in analytical chemistry from Southern University in 1989. Dr. Chen is a member of IEEE, American Chemical Society, National Honorary Woman Chemical Society (IOTA SIGMA PI). 

 

Peter T. Kissinger

PETER T. KISSINGER, Ph.D., is the Chief Advisory Board member in science at ABS. Professor Kissinger was the founder of Bioanalytical Systems, Inc., which he led from 1974-2007, and was a full Professor of Chemistry at Purdue University, West Lafayette, Indiana from 1975- 2019. Dr. Kissinger received a B.S. in Chemistry (1966) from Union College, Schenectady, N.Y., and a Ph.D. in Analytical Chemistry (1970) from the University of North Carolina in Chapel Hill. Before joining the faculty at Purdue in 1975, Kissinger was a Research Associate at the University of Kansas (1970-1972) and an Assistant Professor at Michigan State University (1972-1975). He founded BASi in 1974. Headquartered in West Lafayette, Indiana, BASi also has operations in multiple countries. Dr. Kissinger has published more than 230 scientific papers and is a Fellow of the American Association of Pharmaceutical Scientists and the American Association for the Advancement of Science. In 2005, he became the Chairman of Prosolia, which markets mass spectrometry innovations for life science, industrial, and homeland security applications. In 2007, he and Candice Kissinger founded Phlebotics, Inc., a medical device company focused on diagnostic information for intensive care medicine. In 2008, Professor Kissinger was the Associate Head of the Department of Chemistry at Purdue University, West Lafayette, Indiana. Professor Kissinger has retired from Purdue University in 2019.

Show-Hong Duh

SHOW-HONG DUH, Ph.D. was the Advisory Board Member in clinical pathology at ABS from 2006 to 2020. Dr. Duh was an Associate Professor of Pathology at the University of Maryland School of Medicine since 2005. Dr. Duh received a B.S. degree in Pharmacy in 1970 in Taipei, Taiwan. Dr. Duh received an M.S. degree in Pharmaceutical Sciences in 1981 at North Dakota State University, Fargo, ND. Dr. Duh was Associate Director since 1989 in the Core/Clinical Chemistry Laboratory at the University of Maryland Medical Center. Dr. Duh received Joseph H. Roe Award from American Association for Clinical Chemistry Capital Section (2000). Dr. Duh had more than 20 years of experience in medical device researches included the USFDA’s numerous clinical research projects. Dr. Duh has retired from the University of Maryland Medical Systems in 2020.

Kevin Bowen

KEVIN BOWEN, Engineering Fellow at Raytheon from 2001-2013 as the technical director and the manager at the systems engineering department at Raytheon. Mr. Kevin led Advanced Technology Research and Development teams that developed manned and unmanned surface and undersea vehicle systems for 10 years at Raytheon. Currently, Kevin is the President of Applied Robotics Systems from 2013 to the present, has developing ground and undersea vehicle systems integrated with STEM education for middle and high school students. He is also in charge of C++ and Python vehicle and support system programming. Mr. Kevin Bowen is the Board of Directors in National Defense Industrial Association, is the Chairman for STEM. Mr. Bowen was a corporate Mentor for Dr. Ellen Chen at ABS under the DOD/Raytheon energy storage innovation Mentor-protégée program from 2010 to 2013. Mr. Bowen has retired from Raytheon in 2013.  

Illuminated Structure

LEADERS IN THE FIELD OF
ENERGY TECHONOLGY